03:46 AM EDT, 08/05/2025 (MT Newswires) -- Ardelyx ( ARDX ) reported late Monday a Q2 loss of $0.08 per diluted share, wider than the $0.07 loss per share a year earlier.

Analysts polled by Capital IQ expected $0.13 loss per share.

Revenue for the quarter ended June 30 was $97.7 million, up from $73.2 million a year earlier.

Analysts polled by Capital IQ expected $81.1 million.

The company also said it has appointed Edward Conner as chief medical officer and John Bishop to the newly created position of chief technical operations officer.

Meanwhile, Chief Financial and Operations Officer Justin Renz is expected to leave the company before the end of the year, or until the company has identified a successor.